KYTX LAWSUIT ALERT: Levi & Korsinsky Notifies Kyverna Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Portfolio Pulse from
Levi & Korsinsky, LLP has announced a class action lawsuit against Kyverna Therapeutics, Inc. (NASDAQ: KYTX) for alleged securities fraud. The lawsuit aims to recover losses for investors affected by these allegations.
January 10, 2025 | 11:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kyverna Therapeutics, Inc. is facing a class action lawsuit for alleged securities fraud, which could negatively impact its stock price in the short term.
The announcement of a class action lawsuit for alleged securities fraud is likely to create negative sentiment among investors, potentially leading to a decline in the stock price of Kyverna Therapeutics, Inc. in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100